Infectious Disease Molecular Diagnostics Market (Hepatitis, HIV/CT/NG/HPV and Other Tests)

Table of Contents

ONE: EXECUTIVE SUMMARY

• Introduction
• Overall Molecular Diagnostics Market
• Molecular Diagnostic Technologies
• Molecular Diagnostics In Healthcare
• Global Molecular Diagnostics Market
• Table 1-1: Global Molecular Diagnostics Market (2016-2021) – Infectious Disease, Blood Screening, Histology, Cancer Assays, Transplant, Inherited Diseases ($ Millions)
• Figure 1-1: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
• Conclusions

TWO: INTRODUCTION TO MOLECULAR DIAGNOSTICS

• Introduction
• Nucleic Acid Amplification Test (NAAT) Technologies
• Real-Time Pcr (Qpcr)
• Isothermal Amplification
• Table 2-1: Selected Isothermal Amplification Methods And Platform Examples
• Trends In Nucleic Acid Amplification Testing And Emerging Technologies
• Microarrays
• Table 2-2: Selected Clinical Array Component And Microarray Systems

THREE: MOLECULAR DIAGNOSTICS IN HEALTHCARE

• Introduction
• Reimbursement Environment for Molecular Diagnostics
• Molecular Diagnostics And The Clinical Utility Standard
• Laboratory-Developed Tests Are Here To Stay Conclusions

FOUR: MARKET ANALYSIS

• Market Size and Forecast by Category

• Table 4-1: Market-Available Molecular Diagnostic Platforms – POC, Hospital And Developing World (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test PrincipleMarket Analysis

• Table 4-2: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
• Figure 4-1 Global Molecular Infectious Disease Diagnostics Market (2016) – Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
• Figure 4-2 Global Molecular Infectious Disease Diagnostics Market (2016-2021) – Hepatitis, HIV, HAIs/Sepsis, CT/NG, HPV, Respiratory, Mycobacteria/TB, Other ($ Millions)
• Table 4-3: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
• Figure 4-3: Global Molecular Infectious Disease Diagnostics Market (2016) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
• Figure 4-4: Global Molecular Infectious Disease Diagnostics Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
• Figure 4-5: Global Molecular Infectious Disease Diagnostics Market Share – Abbott Diagnostics, BD, Biomérieux, Cepheid, Hologic, Qiagen, Roche Diagnostics, Siemens Healthcare Diagnostics, Others (%)

• CT/NG, HPV And Women’s Health
• Hepatitis
• HIV
• Hospital-Acquired Infections (HAIs) And Sepsis
• Respiratory
• Tuberculosis
• Market for Molecular Blood Transfusion Diagnostics
  • Introduction
  • Market Analysis
  • Table 4-4: Global NAT Blood Screening (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
  • Figure 4-6: Global NAT Blood Screening Market (2016) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
  • Figure 4-7 Global NAT Blood Screening Market (2016-2021) – United States, Europe, Japan, China, Latin America, Rest Of World ($ Millions)
  • Table 4-5: Commonly Tested Pathogens In Blood Screening
  • Figure 4-8: Global NAT Blood Screening Share – Grifols, Roche Diagnostics, Others (%)
  • New Infectious Disease Threats And Assay Introduction
  • Conclusions

FIVE: COMPANY PROFILES

Abbott Diagnostics

• Table 5-1: Abbott Diagnostics Revenue (2013-2016) ($ Millions)

• Infectious Diseases/qPCR
• Cytogenetics/Oncology/FISH
• Molecular ID/AST

Agilent Technologies

• Table 5-2: Agilent Technologies Revenue (Fy 2013-Fy 2016) ($ Millions)
• Alere
• Table 5-3: Alere Revenue (2013- 2016) ($ Millions)

Amoy Diagnostics

Beckman Coulter (Danaher)

Becton, Dickinson & Co. (BD)

• Table 5-4: Becton, Dickinson & Co. (BD) Revenue (Fy 2013-Fy 2016) ($ Millions)
• Molecular
• Histology/Cytology
• Flow Cytometry

Biomérieux

• Table 5-5: Biomérieux Revenue (2013-2016) ($ Millions)
• Molecular
• Sequencing

Bio-Rad Laboratories

• Transplant Diagnostics
• Molecular Diagnostic Qc Products
• Sequencing

Cepheid (Danaher)

• Table 5-6: Cepheid Revenue (2013-2016) ($ Millions)
• Molecular Hospital-Acquired Infection (HAI) Testing
• Molecular Sexual Health And Women’s Health Testing
• Molecular Critical Infectious Disease Testing
• Molecular Oncology Testing

Covaris

Eiken Chemical

• Table 5-7: Eiken Chemical Revenue (Fy 2013-Fy 2016) ($ Millions)

Grifols

• Table 5-8: Grifols Diagnostic Revenue (2013-2016) ($ Millions)
• Molecular Immunohematology And Specialty Testing Services
• NAT Blood Screening

Hologic

• Table 5-9: Hologic Revenue (Fy 2013-Fy 2016) ($ Millions)
• Molecular Cytology / Histology (HPV)
• Other Molecular (Stis, HIV, Hcv, TB, Respiratory)
• Microbiology (Accuprobe Molecular Culture Id Tests)

Illumina

• Table 5-10: Illumina Revenue (2013-2016) ($ Millions)
• Sequencing
• Translational Research
• Clinical Assay Development
• Industry Lab-Developed Tests
• Arrays

Immucor

• Table 5-11:Immucor Revenue (Fy 2013-Fy 2016) ($ Millions)
• Transfusion Diagnostics
• Transplant Diagnostics
• Immucor Dx Laboratory Service
• Janssen Diagnostics (Johnson & Johnson)

Luminex Corporation

• Table 5-13: Luminex Corporation Revenue (2013- 2016) ($ Millions)
• Business Expansion
• Magpix Multiplexing
• Aries Molecular System

Meridian Bioscience

• Table 5-14: Meridian Bioscience Revenue (Fy 2013-Fy 2016) ($ Millions)

Qiagen

• Table 5-15: Qiagen Revenue (2013-2016) ($ Millions)
• Molecular Infectious Disease
• Cancer Diagnostics
• Transplant Diagnostics
• Next-Generation Sequencing
• Circulating Tumor Cells

Quidel

• Table 5-16: Quidel Revenue (2013-2016) ($ Millions)

Roche Diagnostics

• Table 5-17: Roche Diagnostics Revenue (2013-2016) ($ Millions)
• Molecular Diagnostics
• Blood Screening
• Sequencing
• Liquid Biopsy
• Microbiology

Siemens Healthcare Diagnostics

Thermo Fisher Scientific

• Table 5-18: Thermo Fisher Scientific Revenue (2013-2016) ($ Millions)
• Transplant Diagnostics
• PCR
• Sequencing